A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia

• Published in: Journal of Neural Transmission Vol. 120; no. 12; pp. 1699 - 1707
• Main Authors: Evidente, Virgilio Gerald H., Fernandez, Hubert H., LeDoux, Mark S., Brashear, Allison, Grafe, Susanne, Hanschmann, Angelika, Comella, Cynthia L.
• Format: Journal Article
• Language: English
• Published: Vienna Springer Vienna 01.12.2013; Springer Nature B.V
• Subjects: Adult; Aged; Botulinum Toxins, Type A - therapeutic use; Clinical trials; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Medicine; Medicine & Public Health; Middle Aged; Neurology; Neurology and Preclinical Neurological Studies - Original; Neurology and Preclinical Neurological Studies - Original Article; Neuromuscular Agents - therapeutic use; Neurosciences; Psychiatry; Severity of Illness Index; Torticollis - drug therapy; Treatment Outcome; NT 201; Dystonia; Xeomin; Botulinum toxin; IncobotulinumtoxinA

IncobotulinumtoxinA (Xeomin ® , NT 201), a preparation without accessory (complexing) proteins, has shown comparable efficacy and safety to onabotulinumtoxinA in treating cervical dystonia (CD). This study evaluated the efficacy and safety of repeated incobotulinumtoxinA injections in subjects with...